triamcinolone has been researched along with Anterior Ischemic Optic Neuropathy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, MS; Yang, YY | 1 |
| Kelman, SE | 1 |
| Avci, R; Gelisken, O; Guler, K; Kaderli, B; Yucel, A | 1 |
| Hayreh, SS | 1 |
1 trial(s) available for triamcinolone and Anterior Ischemic Optic Neuropathy
| Article | Year |
|---|---|
Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Male; Middle Aged; Optic Disk; Optic Nerve; Optic Neuritis; Optic Neuropathy, Ischemic; Papilledema; Pilot Projects; Recovery of Function; Retinal Artery; Treatment Outcome; Triamcinolone; Visual Acuity | 2007 |
3 other study(ies) available for triamcinolone and Anterior Ischemic Optic Neuropathy
| Article | Year |
|---|---|
Non-arteritic anterior ischemic optic neuropathy with Cilioretinal artery occlusion: a case report.
Topics: Adrenal Cortex Hormones; Adult; Arterial Occlusive Diseases; Ciliary Arteries; Female; Humans; Optic Neuropathy, Ischemic; Treatment Outcome; Triamcinolone | 2019 |
Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Disease Models, Animal; Humans; Injections; Ophthalmologic Surgical Procedures; Optic Nerve; Optic Neuritis; Optic Neuropathy, Ischemic; Papilledema; Pilot Projects; Treatment Outcome; Triamcinolone; Vitreous Body | 2007 |
Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy.
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Humans; Injections; Observer Variation; Optic Nerve; Optic Neuropathy, Ischemic; Papilledema; Predictive Value of Tests; Reproducibility of Results; Research Design; Retinal Artery; Sample Size; Treatment Outcome; Triamcinolone; Vision, Low; Vitreous Body | 2008 |